| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/05/2006 | EP1641764A1 5-membered heterocycle-based p38 kinase inhibitors |
| 04/05/2006 | EP1641763A2 4-cyanopyrazole-3-carboxamide derivatives preparation and therapeutic application thereof |
| 04/05/2006 | EP1641758A2 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 04/05/2006 | EP1641477A1 Use of parts or extract of amarathus blitoides |
| 04/05/2006 | EP1641468A2 Use of s1p |
| 04/05/2006 | EP1641446A1 Pharmaceutical compositions including an antihistamine and a stimulant and use thereof |
| 04/05/2006 | EP1526849B1 Topical formulations containing ketoprofen stabilised with sulisobenzone |
| 04/05/2006 | EP1465636A4 Compositions and methods for enhancing corticosteriod delivery |
| 04/05/2006 | EP1453777B1 Functionalized higher diamondoids |
| 04/05/2006 | EP1383522B1 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of inflammatory skin conditions |
| 04/05/2006 | EP1372680B1 Biologically active aqueous fraction of an extract obtained from a mangrove plant salvadora persica l |
| 04/05/2006 | EP1370544B1 Nitric oxide donors based on metallic centres |
| 04/05/2006 | EP1333805B1 Cosmetic method of treating skin |
| 04/05/2006 | EP1305319B1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 04/05/2006 | EP1280524B1 Methods and compositions for modulating alpha adrenergic receptor activity |
| 04/05/2006 | EP1244668B1 Purine derivatives, process for their preparation and use thereof |
| 04/05/2006 | EP1235581B1 Use of ribose to prevent cramping and soreness in muscles |
| 04/05/2006 | EP1210104B1 Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions |
| 04/05/2006 | EP1173427B1 Hydroxamic acid derivative |
| 04/05/2006 | EP1086098B1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
| 04/05/2006 | CN1756753A Benzofuran derivative |
| 04/05/2006 | CN1756566A Use of the corticoliberin-urocortin system in the treatment of inflammatory diseases |
| 04/05/2006 | CN1756553A 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof |
| 04/05/2006 | CN1756546A Microglia inhibitors for interrupting interleukin 12 and ifn-gamma-mediated immune reactions |
| 04/05/2006 | CN1754889A Pegylated interferon alpha-1b |
| 04/05/2006 | CN1754880A Process for preparing 2-iminopyrrolidine derivatives |
| 04/05/2006 | CN1754557A Chinese caterpillar fungus formulation preparation method |
| 04/05/2006 | CN1754544A Gound beetle extractions extracted from different parts and heat-free extraction process |
| 04/05/2006 | CN1249087C Novel human G-Protein coupled receptor |
| 04/05/2006 | CN1249086C Melanocortin receptor ligands |
| 04/05/2006 | CN1249074C 2-aminocarbonyl-9H-punine derivatives |
| 04/05/2006 | CN1249066C 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 04/05/2006 | CN1249063C Immunoregulatory compounds |
| 04/05/2006 | CN1249059C Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/05/2006 | CN1249056C Inhibitors of dipeptidyl peptidase IV |
| 04/05/2006 | CN1249055C Piperazinylcarbonylquinolines and -isoquinolines |
| 04/05/2006 | CN1249039C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I |
| 04/05/2006 | CN1249033C Cyclic amp-specific phosphodiesterase inhibitors |
| 04/05/2006 | CN1249026C N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 04/05/2006 | CN1249025C Aminobenzophenones as inhibiotors of IL-1 beta and TNF-alpha |
| 04/05/2006 | CN1249019C Naphthylsalicylanilides as antimicrobial and antiinflammatory agents |
| 04/05/2006 | CN1248734C Matrix protein compositions for wound healing |
| 04/05/2006 | CN1248727C Capsule for treating rheumatism and its manufacturing method |
| 04/05/2006 | CN1248723C Medicinal liquor for rheumatism and preparation method thereof |
| 04/05/2006 | CN1248693C Sustained release formulation of glucosamine salt and preparation |
| 04/05/2006 | CN1248685C Analgesic/anti-inflammatory patches for topical use |
| 04/05/2006 | CN1248681C Solid orally-dispersible pharmaceutical formulation |
| 04/04/2006 | US7024217 Access parameter adaptation and packet data resource management using detailed mobile status information |
| 04/04/2006 | US7022856 Carboline derivatives |
| 04/04/2006 | US7022849 Quinazoline and pyrido[2,3-d]pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 04/04/2006 | US7022739 Substituted 1-aminobutan-3-ol compounds |
| 04/04/2006 | US7022734 Use of a transition metal complex, other than deferoxamine-manganese, hemin, diethyldithiocarbamic acid complexes or an iron hemoprotein, in the manufacture of a medicament for the therapy of septic shock |
| 04/04/2006 | US7022730 Protein tyrosine phosphatases inhibitors |
| 04/04/2006 | US7022716 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 04/04/2006 | US7022711 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimidin-7-ones |
| 04/04/2006 | US7022706 Central nervous system disorders |
| 04/04/2006 | US7022690 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 04/04/2006 | US7022687 for treatment of allergies and airway disorders such as allergic rhinitis |
| 04/04/2006 | US7022678 Pregabalin lactose conjugates |
| 04/04/2006 | US7022500 Humanized immunoglobulins |
| 04/04/2006 | US7022485 immunogens or target antigens comprising citrullinated polypeptide derived from fragments of fibrinogen; prophylaxis of inflammatory disorders |
| 04/04/2006 | US7022312 Condensation aerosol as doage forms, is produced by heating a thin layer containing of dolasetron, granisetron or metoclopramide to form vapor, condense into an aerosol; fast producing peak plasma concentrations |
| 04/04/2006 | CA2379521C Methods to identify compounds that modulate rage |
| 04/04/2006 | CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 03/30/2006 | WO2006033627A1 Compounds, compositions containing them, preparation thereof and uses thereof iiii |
| 03/30/2006 | WO2006033620A1 New heterocyclic amides |
| 03/30/2006 | WO2006033481A1 Soluble toll-like receptor 4 protein |
| 03/30/2006 | WO2006032144A1 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using fucans from various echinoderm sources |
| 03/30/2006 | WO2006032143A1 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans |
| 03/30/2006 | WO2006014864A3 Methods and compositions for reducing c-reactive protein |
| 03/30/2006 | WO2006011024A3 New tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 03/30/2006 | WO2005097192A3 Active substance combination of a carbinol compound and an opioid |
| 03/30/2006 | WO2005030124A3 Antibodies to m-csf |
| 03/30/2006 | WO2003014294A3 Tacis and br3 polypeptides and uses thereof |
| 03/30/2006 | US20060069265 Reacting cysteine (or a salt or an ester) and an aryl carboxylic acid to form a thiazoline ring; stereospecifically alkylating the thiazoline ring, and hydrolyzing the thiazoline ring to obtain a 2-alkylcysteine; chelation |
| 03/30/2006 | US20060069149 Thiadibenzoazulene derivatives for the treatment of inflammatory diseases |
| 03/30/2006 | US20060069131 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 03/30/2006 | US20060069130 Novel crystals |
| 03/30/2006 | US20060069126 Pharmaceutically active isoindoline derivatives |
| 03/30/2006 | US20060069092 Pharmaceutical compositions for the treatment of diseases related to neurotrophines |
| 03/30/2006 | US20060069090 Triazine compounds |
| 03/30/2006 | US20060069088 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 03/30/2006 | US20060069084 Methods of inhibiting kinases |
| 03/30/2006 | US20060068471 Soluble zcytor 11 cytokine receptors |
| 03/30/2006 | US20060068035 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals |
| 03/30/2006 | US20060067982 Encasing a core made of a siloxane-based elastomer containing dexamethasone, betamethasone, beclomethasone, and/or budesonide with a membrane made of the same or a different elastomer; and shaping the device into a shape suitable for implantation into the ear or nose |
| 03/30/2006 | US20060067966 Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| 03/30/2006 | US20060067932 Antagonists specific for denatured collagen and methods of using same |
| 03/30/2006 | CA2623471A1 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans |
| 03/30/2006 | CA2582512A1 Compounds, compositions containing them, preparations thereof and uses thereof ii |
| 03/30/2006 | CA2580881A1 Use of microproteins as tryptase inhibitors |
| 03/30/2006 | CA2577818A1 New heterocyclic amides |
| 03/29/2006 | EP1640898A1 Medical care self-cell delivery support system, medical care self-cell delivery support financial system, and their methods |
| 03/29/2006 | EP1640449A1 Cell differentiation inhibiting agent, cell culture method using the same, culture medium and cultured cell line |
| 03/29/2006 | EP1640381A2 Neurotrophic growth factor |
| 03/29/2006 | EP1640011A1 Novel complexes of fatty acid esters of polyhydroxylalkanes and pyridine carboxy derivates |
| 03/29/2006 | EP1640010A1 Agent inducing increase in bone mass |
| 03/29/2006 | EP1640003A2 Compositions comprising a Cyclooxygenase-2 Inhibitor and a Leukotriene B4 receptor antagonist |
| 03/29/2006 | EP1639994A2 Topical composition comprising N-acetylaldosamines or N-acetylamino acids |
| 03/29/2006 | EP1638979A1 Thienopyridone derivatives as kinase inhibitors |